Lianhong Pan

882 total citations · 2 hit papers
18 papers, 653 citations indexed

About

Lianhong Pan is a scholar working on Molecular Biology, Rheumatology and Cancer Research. According to data from OpenAlex, Lianhong Pan has authored 18 papers receiving a total of 653 indexed citations (citations by other indexed papers that have themselves been cited), including 10 papers in Molecular Biology, 6 papers in Rheumatology and 6 papers in Cancer Research. Recurrent topics in Lianhong Pan's work include Cancer, Hypoxia, and Metabolism (4 papers), GDF15 and Related Biomarkers (3 papers) and Osteoarthritis Treatment and Mechanisms (3 papers). Lianhong Pan is often cited by papers focused on Cancer, Hypoxia, and Metabolism (4 papers), GDF15 and Related Biomarkers (3 papers) and Osteoarthritis Treatment and Mechanisms (3 papers). Lianhong Pan collaborates with scholars based in China and Pakistan. Lianhong Pan's co-authors include Li Yang, Jiaqin Wu, Chunli Wang, Kang Xu, Fan Feng, Wanqian Liu, Juanjuan Han, Shunxi Wang, Yonghui Zhang and Lanqing Li and has published in prestigious journals such as International Journal of Molecular Sciences, Journal of Controlled Release and Advanced Science.

In The Last Decade

Lianhong Pan

16 papers receiving 648 citations

Hit Papers

Demethylzeylasteral targets lactate by inhibiting histone... 2022 2026 2023 2024 2022 2024 50 100 150 200 250

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Lianhong Pan China 11 415 214 63 58 55 18 653
Dan Huang China 18 432 1.0× 160 0.7× 47 0.7× 34 0.6× 87 1.6× 69 869
Fangliang Zhou China 11 391 0.9× 182 0.9× 60 1.0× 21 0.4× 67 1.2× 19 627
Ya He China 12 305 0.7× 150 0.7× 51 0.8× 69 1.2× 82 1.5× 24 649
I‐Lu Lai Taiwan 16 567 1.4× 270 1.3× 59 0.9× 30 0.5× 137 2.5× 20 775
Yang Cheng China 14 331 0.8× 206 1.0× 34 0.5× 23 0.4× 63 1.1× 36 606
AmirReza Hesari Iran 13 315 0.8× 163 0.8× 30 0.5× 19 0.3× 92 1.7× 17 530
Young‐Joo Jeon South Korea 16 343 0.8× 92 0.4× 36 0.6× 26 0.4× 71 1.3× 36 609

Countries citing papers authored by Lianhong Pan

Since Specialization
Citations

This map shows the geographic impact of Lianhong Pan's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Lianhong Pan with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Lianhong Pan more than expected).

Fields of papers citing papers by Lianhong Pan

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Lianhong Pan. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Lianhong Pan. The network helps show where Lianhong Pan may publish in the future.

Co-authorship network of co-authors of Lianhong Pan

This figure shows the co-authorship network connecting the top 25 collaborators of Lianhong Pan. A scholar is included among the top collaborators of Lianhong Pan based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Lianhong Pan. Lianhong Pan is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

18 of 18 papers shown
1.
Zhang, Xiyang, Dilong Chen, Hua Yang, et al.. (2025). Eupalinolide A inhibits cancer progression and induces ferroptosis and apoptosis by targeting the AMPK/mTOR/SCD1 signalling in non-small cell lung cancer. Frontiers in Pharmacology. 16. 1649314–1649314.
2.
Wang, Sixiang, Yan Gao, Fan Feng, et al.. (2025). Acid neutralization and metal-phenolic nanomedicine on-demand release microspheres for reversing cartilage degeneration. Journal of Controlled Release. 390. 114523–114523. 1 indexed citations
3.
Feng, Fan, Jiaqin Wu, Qingjia Chi, et al.. (2024). Lactylome Analysis Unveils Lactylation‐Dependent Mechanisms of Stemness Remodeling in the Liver Cancer Stem Cells. Advanced Science. 11(38). e2405975–e2405975. 81 indexed citations breakdown →
4.
Wang, Shunshun, Juanjuan Han, Zijun Wang, et al.. (2024). Targeted Therapy of Tumors and Cancer Stem Cells based on Oxidant-regulated Redox Pathway and its Mechanism. Current Computer - Aided Drug Design. 21(4). 425–440. 1 indexed citations
5.
Li, Jiaxin, Huan Liu, Na Zhou, et al.. (2023). The inhibitory function of GDF11/BMP11 in liver cancer by inducing apoptosis and ROS–JNK pathway. ONCOLOGIE. 25(2). 187–197. 3 indexed citations
6.
Wang, Zijun, Lanqing Li, Shunshun Wang, et al.. (2022). The role of the gut microbiota and probiotics associated with microbial metabolisms in cancer prevention and therapy. Frontiers in Pharmacology. 13. 1025860–1025860. 35 indexed citations
7.
Pan, Lianhong, Fan Feng, Jiaqin Wu, et al.. (2022). Demethylzeylasteral targets lactate by inhibiting histone lactylation to suppress the tumorigenicity of liver cancer stem cells. Pharmacological Research. 181. 106270–106270. 267 indexed citations breakdown →
8.
Feng, Fan, Lianhong Pan, Jiaqin Wu, et al.. (2022). Schisantherin A inhibits cell proliferation by regulating glucose metabolism pathway in hepatocellular carcinoma. Frontiers in Pharmacology. 13. 1019486–1019486. 7 indexed citations
9.
Feng, Fan, Mingying Liu, Lianhong Pan, et al.. (2022). Biomechanical Regulatory Factors and Therapeutic Targets in Keloid Fibrosis. Frontiers in Pharmacology. 13. 906212–906212. 34 indexed citations
10.
Feng, Fan, Lianhong Pan, Jiaqin Wu, et al.. (2021). Cepharanthine inhibits hepatocellular carcinoma cell growth and proliferation by regulating amino acid metabolism and suppresses tumorigenesis in vivo. International Journal of Biological Sciences. 17(15). 4340–4352. 42 indexed citations
11.
Wu, Jiaqin, Yuna Qian, Cheng Chen, et al.. (2021). Hesperetin Exhibits Anti-Inflammatory Effects on Chondrocytes via the AMPK Pathway to Attenuate Anterior Cruciate Ligament Transection-Induced Osteoarthritis. Frontiers in Pharmacology. 12. 15 indexed citations
12.
Pan, Lianhong, Fan Feng, Jiaqin Wu, et al.. (2021). Diosmetin inhibits cell growth and proliferation by regulating the cell cycle and lipid metabolism pathway in hepatocellular carcinoma. Food & Function. 12(23). 12036–12046. 26 indexed citations
13.
Li, Xiaoshan, et al.. (2020). Visnagin ameliorates myocardial ischemia/reperfusion injury through the promotion of autophagy and the inhibition of apoptosis. European Journal of Histochemistry. 64(s2). 11 indexed citations
14.
Pang, Yi, et al.. (2019). TP53BP2 decreases cell proliferation and induces autophagy in neuroblastoma cell lines. Oncology Letters. 17(6). 4976–4984. 6 indexed citations
15.
Pan, Lianhong & Yang Li. (2019). Effect of Icariin on Osteoarthritis Fibroblast-Like Synoviocytes: An In Vitro Study. Molecular & cellular biomechanics. 16(S2). 118–118. 1 indexed citations
16.
Pan, Lianhong, et al.. (2018). GDF11/BMP11 as a novel tumor marker for liver cancer. Experimental and Therapeutic Medicine. 15(4). 3495–3500. 21 indexed citations
17.
Pan, Lianhong, Yonghui Zhang, Na Chen, & Li Yang. (2017). Icariin Regulates Cellular Functions and Gene Expression of Osteoarthritis Patient-Derived Human Fibroblast-Like Synoviocytes. International Journal of Molecular Sciences. 18(12). 2656–2656. 42 indexed citations
18.
Zhang, Yonghui, Yong Wei, Dan Liu, et al.. (2017). Role of growth differentiation factor 11 in development, physiology and disease. Oncotarget. 8(46). 81604–81616. 60 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026